Literature DB >> 8025048

Chronic ocular hypertension alters local retinal responsiveness.

R Ofri1, W W Dawson, K Foli, K N Gelatt.   

Abstract

Electrophysiological responses of the retina and visual cortex to a series of grating stimuli (6-768 minutes of arc) were recorded in seven sessions using normal beagles, 21 sessions using beagles afflicted with inherited ocular hypertension, and 12 sessions using rhesus monkeys. A 15 degrees field centred around the animal's area centralis or fovea was used to stimulate the central retina. A 30 degrees field, centred on the same spot, was then used to stimulate the larger area. Two recording series were completed on each animal, with both field sizes presented in each recording session. The first recording took place 30 minutes after and the second 2 hours after the injection of thiamylal sodium. Only the signals from the toroidal 15 degrees of the retina of the hypertensive dogs were remarkably larger during the second recording (p = 0.001). No significant differences were found between the two recordings from the retinas of normal dogs or monkeys, nor were there any significant differences between the two recordings from above the cortex in any group. Several hypotheses are proposed to explain the basis for the interaction of thiamylal with the more peripheral retinal function in clinically glaucomatous dogs.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8025048      PMCID: PMC504585          DOI: 10.1136/bjo.77.8.502

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  27 in total

1.  Phase of suppression following each retinal b-wave in flicker.

Authors:  G ARDEN; R GRANIT; F PONTE
Journal:  J Neurophysiol       Date:  1960-05       Impact factor: 2.714

2.  [Changes in the electroretinogram of the rat induced by local intra-arterial injection of potassium, veratrine and narcotics].

Authors:  P DANIS
Journal:  J Physiol (Paris)       Date:  1956 May-Jun

3.  Flash and pattern electroretinograms during and after acute intraocular pressure elevation in cats.

Authors:  R Siliprandi; M G Bucci; R Canella; G Carmignoto
Journal:  Invest Ophthalmol Vis Sci       Date:  1988-04       Impact factor: 4.799

4.  Very large neurons of the inner retina of humans and other mammals.

Authors:  W W Dawson; M N Hawthorne; R Parmer; G M Hope; R Hueter
Journal:  Retina       Date:  1989       Impact factor: 4.256

5.  Normal visual cortical-evoked response in the dog.

Authors:  D R Howard; J E Breazile
Journal:  Am J Vet Res       Date:  1972-11       Impact factor: 1.156

6.  Signs of early damage in glaucomatous monkey eyes: low spatial frequency losses in the pattern ERG and VEP.

Authors:  M S Marx; S M Podos; I Bodis-Wollner; P Y Lee; R F Wang; C Severin
Journal:  Exp Eye Res       Date:  1988-02       Impact factor: 3.467

Review 7.  Visually evoked potentials: theory, techniques and clinical applications.

Authors:  S Sokol
Journal:  Surv Ophthalmol       Date:  1976 Jul-Aug       Impact factor: 6.048

8.  Flash and pattern electroretinograms in normal and laser-induced glaucomatous primate eyes.

Authors:  M S Marx; S M Podos; I Bodis-Wollner; J R Howard-Williams; M J Siegel; C S Teitelbaum; E L Maclin; C Severin
Journal:  Invest Ophthalmol Vis Sci       Date:  1986-03       Impact factor: 4.799

9.  Inheritance of primary glaucoma in the beagle.

Authors:  K N Gelatt; G G Gum
Journal:  Am J Vet Res       Date:  1981-10       Impact factor: 1.156

10.  Electroretinographic components of the canine visual evoked response.

Authors:  G A Malnati; A E Marshall; D B Coulter
Journal:  Am J Vet Res       Date:  1981-01       Impact factor: 1.156

View more
  1 in total

1.  T-cell-based vaccination for morphological and functional neuroprotection in a rat model of chronically elevated intraocular pressure.

Authors:  Sharon Bakalash; Gil Ben-Shlomo; Gil Ben Shlomo; Eyal Aloni; Iftach Shaked; Larry Wheeler; Ron Ofri; Michal Schwartz
Journal:  J Mol Med (Berl)       Date:  2005-08-12       Impact factor: 4.599

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.